Cardinal Health Inc

Cardinal Health’s resilient market cap and diverse pharmacy‑distribution portfolio underscore its pivotal role in U.S. healthcare, with a 2025 stock still near its 52‑week peak.

Cardinal Health Q1 beats estimates with 22% revenue growth, boosts EPS outlook, and hits a new 52‑week high—investors see strong value‑added upside.

Cardinal Health, Inc. has demonstrated a significant recovery in its stock performance, driven by its diversified business model, strategic innovations, and global expansion efforts, positioning the company as a critical component in the healthcare …

Cardinal Health Inc. reports strong Q4 and FY2025 results, raises FY2026 guidance, and makes a strategic acquisition of Solaris Health, positioning the company for continued growth and leadership in the healthcare sector.

Cardinal Health Inc. has announced a strong financial outlook, including a 13% projected growth in earnings, and strategic partnerships that position the company for sustained growth and value creation in the healthcare industry.

Cardinal Health Inc. reported a strong third-quarter performance, exceeding expectations with a 19% revenue increase and raising its adjusted earnings guidance for fiscal year 2025.

Cardinal Health Inc. has demonstrated significant growth over the past decade, with its shares increasing by 52.03% in value, and is well-positioned for continued success in the healthcare sector.